203 related articles for article (PubMed ID: 35805156)
21. Macrophage-stimulating protein attenuates hydrogen peroxide-induced apoptosis in human renal HK-2 cells.
Lee KE; Kim EY; Kim CS; Choi JS; Bae EH; Ma SK; Park JS; Jung YD; Kim SH; Lee JU; Kim SW
Eur J Pharmacol; 2013 Sep; 715(1-3):304-11. PubMed ID: 23726950
[TBL] [Abstract][Full Text] [Related]
22. Healthy CD4+ T lymphocytes are not affected by targeted therapies against the PI3K/Akt/mTOR pathway in T-cell acute lymphoblastic leukemia.
Alameen AA; Simioni C; Martelli AM; Zauli G; Ultimo S; McCubrey JA; Gonelli A; Marisi G; Ulivi P; Capitani S; Neri LM
Oncotarget; 2016 Aug; 7(34):55690-55703. PubMed ID: 27494886
[TBL] [Abstract][Full Text] [Related]
23. [Anti-leukemia effect of oridonin on T-cell acute lymphoblastic leukemia].
Guo Y; Shan QQ; Gong YP; Lin J; Yang X
Sichuan Da Xue Xue Bao Yi Xue Ban; 2014 Nov; 45(6):903-7. PubMed ID: 25571712
[TBL] [Abstract][Full Text] [Related]
24. Either IL-7 activation of JAK-STAT or BEZ inhibition of PI3K-AKT-mTOR pathways dominates the single-cell phosphosignature of
Kuzilková D; Bugarin C; Rejlova K; Schulz AR; Mei HE; Paganin M; Biffi A; Biondi A; Kalina T; Gaipa G
Haematologica; 2022 Jun; 107(6):1293-1310. PubMed ID: 34670357
[TBL] [Abstract][Full Text] [Related]
25. Calcineurin complex isolated from T-cell acute lymphoblastic leukemia (T-ALL) cells identifies new signaling pathways including mTOR/AKT/S6K whose inhibition synergize with calcineurin inhibition to promote T-ALL cell death.
Tosello V; Saccomani V; Yu J; Bordin F; Amadori A; Piovan E
Oncotarget; 2016 Jul; 7(29):45715-45729. PubMed ID: 27304189
[TBL] [Abstract][Full Text] [Related]
26. Comprehensive analysis of T cell leukemia signals reveals heterogeneity in the PI3 kinase-Akt pathway and limitations of PI3 kinase inhibitors as monotherapy.
Ksionda O; Mues M; Wandler AM; Donker L; Tenhagen M; Jun J; Ducker GS; Matlawska-Wasowska K; Shannon K; Shokat KM; Roose JP
PLoS One; 2018; 13(5):e0193849. PubMed ID: 29799846
[TBL] [Abstract][Full Text] [Related]
27. Single-cell analysis of siRNA-mediated gene silencing using multiparameter flow cytometry.
Chan SM; Olson JA; Utz PJ
Cytometry A; 2006 Feb; 69(2):59-65. PubMed ID: 16419066
[TBL] [Abstract][Full Text] [Related]
28. A small molecule inhibitor of Pim protein kinases blocks the growth of precursor T-cell lymphoblastic leukemia/lymphoma.
Lin YW; Beharry ZM; Hill EG; Song JH; Wang W; Xia Z; Zhang Z; Aplan PD; Aster JC; Smith CD; Kraft AS
Blood; 2010 Jan; 115(4):824-33. PubMed ID: 19965690
[TBL] [Abstract][Full Text] [Related]
29. The adaptor protein NTAL enhances proximal signaling and potentiates corticosteroid-induced apoptosis in T-ALL.
Svojgr K; Kalina T; Kanderova V; Skopcova T; Brdicka T; Zuna J
Exp Hematol; 2012 May; 40(5):379-85. PubMed ID: 22269118
[TBL] [Abstract][Full Text] [Related]
30. Network-based systems pharmacology reveals heterogeneity in LCK and BCL2 signaling and therapeutic sensitivity of T-cell acute lymphoblastic leukemia.
Gocho Y; Liu J; Hu J; Yang W; Dharia NV; Zhang J; Shi H; Du G; John A; Lin TN; Hunt J; Huang X; Ju B; Rowland L; Shi L; Maxwell D; Smart B; Crews KR; Yang W; Hagiwara K; Zhang Y; Roberts K; Wang H; Jabbour E; Stock W; Eisfelder B; Paietta E; Newman S; Roti G; Litzow M; Easton J; Zhang J; Peng J; Chi H; Pounds S; Relling MV; Inaba H; Zhu X; Kornblau S; Pui CH; Konopleva M; Teachey D; Mullighan CG; Stegmaier K; Evans WE; Yu J; Yang JJ
Nat Cancer; 2021 Mar; 2(3):284-299. PubMed ID: 34151288
[TBL] [Abstract][Full Text] [Related]
31. Triple Akt inhibition as a new therapeutic strategy in T-cell acute lymphoblastic leukemia.
Cani A; Simioni C; Martelli AM; Zauli G; Tabellini G; Ultimo S; McCubrey JA; Capitani S; Neri LM
Oncotarget; 2015 Mar; 6(9):6597-610. PubMed ID: 25788264
[TBL] [Abstract][Full Text] [Related]
32. Activity of the novel dual phosphatidylinositol 3-kinase/mammalian target of rapamycin inhibitor NVP-BEZ235 against T-cell acute lymphoblastic leukemia.
Chiarini F; Grimaldi C; Ricci F; Tazzari PL; Evangelisti C; Ognibene A; Battistelli M; Falcieri E; Melchionda F; Pession A; Pagliaro P; McCubrey JA; Martelli AM
Cancer Res; 2010 Oct; 70(20):8097-107. PubMed ID: 20876803
[TBL] [Abstract][Full Text] [Related]
33. Curcumin potentiates antitumor activity of L-asparaginase via inhibition of the AKT signaling pathway in acute lymphoblastic leukemia.
Wang H; Geng QR; Wang L; Lu Y
Leuk Lymphoma; 2012 Jul; 53(7):1376-82. PubMed ID: 22185211
[TBL] [Abstract][Full Text] [Related]
34. In vitro combinatorial anti-proliferative and immunosuppressive effects of Brucea javanica extract with CX-4945 and imatinib in human T-cell acute lymphoblastic leukemia cells.
Jung JI; Kim SY; Park KY; Sydara K; Lee SW; Kim SA; Kim J
Biomed Pharmacother; 2018 Oct; 106():403-410. PubMed ID: 29966986
[TBL] [Abstract][Full Text] [Related]
35. Expression of SODD and P65 in ALL of children and its relationship with chemotherapeutic drugs.
Tao H; Hu Q; Fang J; Liu A; Liu S; Zhang L; Hu Y
J Huazhong Univ Sci Technolog Med Sci; 2007 Jun; 27(3):326-9. PubMed ID: 17641854
[TBL] [Abstract][Full Text] [Related]
36. [Statins Regulate the Proliferation and Apoptosis of T-ALL Cells through the Inhibition of Akt Pathway].
Wang JJ; Tian Y; Xu KL; Fu RX; Niu MS; Zhao K
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2018 Apr; 26(2):359-367. PubMed ID: 29665899
[TBL] [Abstract][Full Text] [Related]
37. Signaling effects of sodium hydrosulfide in healthy donor peripheral blood mononuclear cells.
Sulen A; Gullaksen SE; Bader L; McClymont DW; Skavland J; Gavasso S; Gjertsen BT
Pharmacol Res; 2016 Nov; 113(Pt A):216-227. PubMed ID: 27543462
[TBL] [Abstract][Full Text] [Related]
38. Inhibition of c-MYC with involvement of ERK/JNK/MAPK and AKT pathways as a novel mechanism for shikonin and its derivatives in killing leukemia cells.
Zhao Q; Assimopoulou AN; Klauck SM; Damianakos H; Chinou I; Kretschmer N; Rios JL; Papageorgiou VP; Bauer R; Efferth T
Oncotarget; 2015 Nov; 6(36):38934-51. PubMed ID: 26472107
[TBL] [Abstract][Full Text] [Related]
39. Altersolanol B, a fungal tetrahydroanthraquinone, inhibits the proliferation of estrogen receptor-expressing (ER+) human breast adenocarcinoma by modulating PI3K/AKT, p38/ERK MAPK and associated signaling pathways.
Siraj MA; Jacobs AT; Tan GT
Chem Biol Interact; 2022 May; 359():109916. PubMed ID: 35346647
[TBL] [Abstract][Full Text] [Related]
40. MicroRNA181a Is Overexpressed in T-Cell Leukemia/Lymphoma and Related to Chemoresistance.
Yan ZX; Zheng Z; Xue W; Zhao MZ; Fei XC; Wu LL; Huang LM; Leboeuf C; Janin A; Wang L; Zhao WL
Biomed Res Int; 2015; 2015():197241. PubMed ID: 26436088
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
